HEADER TOXIN 29-JUN-12 4FVV TITLE CRYSTAL STRUCTURE OF HCR/D-SA-GBL1/C COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEUROTOXIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RECEPTOR BINDING DOMAIN, UNP RESIDUES 862-1285; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CLOSTRIDIUM BOTULINUM; SOURCE 3 ORGANISM_TAXID: 1491; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS BOTULINUM TOXIN, GANGLIOSIDE BING LOOP, GANGLIOSIDE, TOXIN EXPDTA X-RAY DIFFRACTION AUTHOR Z.FU,A.KARALEWITZ,M.R.BALDWIN,J.-J.P.KIM,J.T.BARBIERI REVDAT 4 13-SEP-23 4FVV 1 HETSYN REVDAT 3 29-JUL-20 4FVV 1 COMPND REMARK HETNAM SITE REVDAT 2 12-DEC-12 4FVV 1 JRNL REVDAT 1 24-OCT-12 4FVV 0 JRNL AUTH A.P.KARALEWITZ,Z.FU,M.R.BALDWIN,J.J.KIM,J.T.BARBIERI JRNL TITL BOTULINUM NEUROTOXIN SEROTYPE C ASSOCIATES WITH DUAL JRNL TITL 2 GANGLIOSIDE RECEPTORS TO FACILITATE CELL ENTRY. JRNL REF J.BIOL.CHEM. V. 287 40806 2012 JRNL REFN ISSN 0021-9258 JRNL PMID 23027864 JRNL DOI 10.1074/JBC.M112.404244 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.3 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.38 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 52530.940 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.0 REMARK 3 NUMBER OF REFLECTIONS : 29067 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1429 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.80 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 81.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2458 REMARK 3 BIN R VALUE (WORKING SET) : 0.3170 REMARK 3 BIN FREE R VALUE : 0.4210 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 134 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.036 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6741 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 190 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.88000 REMARK 3 B22 (A**2) : -3.38000 REMARK 3 B33 (A**2) : -0.50000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.43 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.56 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.720 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.320 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.310 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.660 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.520 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 28.50 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : SO4.PAR REMARK 3 PARAMETER FILE 6 : GOL.PAR REMARK 3 PARAMETER FILE 7 : SLB.PAR REMARK 3 PARAMETER FILE 8 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : SO4.TOP REMARK 3 TOPOLOGY FILE 6 : GOL.TOP REMARK 3 TOPOLOGY FILE 7 : SLB.TOP REMARK 3 TOPOLOGY FILE 8 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED MISSING REMARK 3 RESIDUES THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 3 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 3 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I='EXPRESSION TAG' CODE.) REMARK 4 REMARK 4 4FVV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JUL-12. REMARK 100 THE DEPOSITION ID IS D_1000073420. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-MAY-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31121 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 39.380 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.11300 REMARK 200 FOR THE DATA SET : 9.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.50500 REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASES REMARK 200 STARTING MODEL: PDB ENTRY 3N7L REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% PEG5K-MME, 50 MM MGSO4, 0.1 M REMARK 280 HEPPS BUFFER, PH 8.5, EVAPORATION, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 41.30150 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 77.31500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 90.51450 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 41.30150 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 77.31500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 90.51450 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 41.30150 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 77.31500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 90.51450 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 41.30150 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 77.31500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 90.51450 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 S SO4 A1302 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 862 REMARK 465 GLU A 1032 REMARK 465 ASN A 1051 REMARK 465 THR A 1052 REMARK 465 GLY A 1053 REMARK 465 LEU A 1054 REMARK 465 ILE A 1055 REMARK 465 THR A 1056 REMARK 465 SER A 1057 REMARK 465 ASP A 1058 REMARK 465 GLU A 1284 REMARK 465 ASN B 862 REMARK 465 GLU B 1032 REMARK 465 LEU B 1054 REMARK 465 ILE B 1055 REMARK 465 THR B 1056 REMARK 465 SER B 1057 REMARK 465 ASP B 1058 REMARK 465 GLU B 1284 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A1059 OG REMARK 470 ASP A1060 CG OD1 OD2 REMARK 470 SER B1059 OG REMARK 470 ASP B1060 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A1192 C - N - CA ANGL. DEV. = 10.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 910 -67.31 -104.23 REMARK 500 ASN A 922 -166.41 -68.90 REMARK 500 ASN A 924 153.73 -41.88 REMARK 500 GLU A 932 -79.28 -104.32 REMARK 500 PHE A 938 145.60 -173.98 REMARK 500 LYS A 944 47.52 77.75 REMARK 500 ASN A 948 41.61 -93.25 REMARK 500 SER A 957 46.22 -141.46 REMARK 500 LYS A 959 -81.31 -91.48 REMARK 500 ASN A 960 78.23 -116.16 REMARK 500 ILE A 969 -90.14 -100.44 REMARK 500 SER A 970 -75.33 -95.91 REMARK 500 ASN A 982 -84.32 -115.40 REMARK 500 GLU A 984 131.73 -175.90 REMARK 500 ASP A 986 138.17 -175.88 REMARK 500 ASP A 992 103.70 -56.01 REMARK 500 ALA A1073 40.38 -92.48 REMARK 500 TYR A1090 78.49 -101.53 REMARK 500 ASN A1139 45.59 -160.17 REMARK 500 GLU A1161 41.61 -104.31 REMARK 500 ILE A1170 -79.45 -88.79 REMARK 500 ASP A1171 -75.46 -78.43 REMARK 500 ASN A1172 15.68 -157.79 REMARK 500 TYR A1206 21.10 -144.07 REMARK 500 CYS A1214 89.70 -150.05 REMARK 500 ALA A1221 -159.29 -126.98 REMARK 500 SER A1239 -155.45 -115.32 REMARK 500 HIS A1265 83.67 -165.61 REMARK 500 ASP B 866 -7.40 -59.77 REMARK 500 ASN B 886 59.87 36.28 REMARK 500 ASN B 922 -166.34 -79.98 REMARK 500 GLU B 932 -77.17 -117.09 REMARK 500 LYS B 944 35.41 81.24 REMARK 500 SER B 957 48.13 -145.26 REMARK 500 LYS B 959 -77.81 -98.13 REMARK 500 ASN B 960 68.39 -109.58 REMARK 500 SER B 970 -138.19 51.06 REMARK 500 ASN B 982 -70.83 -106.23 REMARK 500 GLU B 984 120.46 -172.56 REMARK 500 ASN B 996 57.98 -147.36 REMARK 500 ILE B1036 148.70 -172.26 REMARK 500 GLN B1045 137.78 -174.59 REMARK 500 ALA B1073 38.77 -82.96 REMARK 500 TYR B1115 59.84 -146.22 REMARK 500 ASN B1139 35.66 -150.09 REMARK 500 ILE B1170 -83.99 -74.93 REMARK 500 ASN B1172 3.68 -156.10 REMARK 500 ASP B1189 19.87 56.87 REMARK 500 MET B1200 -39.49 -39.96 REMARK 500 SER B1239 -144.04 -106.68 REMARK 500 REMARK 500 THIS ENTRY HAS 51 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3N7L RELATED DB: PDB REMARK 900 THE LOOP OF 9 RESIDUES, KLGDDYWFN IS REPLACED BY 8 RESIDUES, REMARK 900 RLGGDWYR REMARK 999 REMARK 999 SEQUENCE REMARK 999 LOOP RESIDUES OF KLGDDYWFN(1246-1254) REPLACED BY RLGGDWYR(THE LOOP REMARK 999 OF HCRC). DBREF 4FVV A 862 1284 UNP Q9LBR1 Q9LBR1_CLOBO 862 1285 DBREF 4FVV B 862 1284 UNP Q9LBR1 Q9LBR1_CLOBO 862 1285 SEQADV 4FVV ARG A 1246 UNP Q9LBR1 LYS 1246 SEE REMARK 999 SEQADV 4FVV GLY A 1249 UNP Q9LBR1 ASP 1249 SEE REMARK 999 SEQADV 4FVV TYR A 1252 UNP Q9LBR1 PHE 1253 SEE REMARK 999 SEQADV 4FVV ARG A 1253 UNP Q9LBR1 ASN 1254 SEE REMARK 999 SEQADV 4FVV ARG B 1246 UNP Q9LBR1 LYS 1246 SEE REMARK 999 SEQADV 4FVV GLY B 1249 UNP Q9LBR1 ASP 1249 SEE REMARK 999 SEQADV 4FVV TYR B 1252 UNP Q9LBR1 PHE 1253 SEE REMARK 999 SEQADV 4FVV ARG B 1253 UNP Q9LBR1 ASN 1254 SEE REMARK 999 SEQRES 1 A 423 ASN SER ILE ASN ASP SER LYS ILE LEU SER LEU GLN ASN SEQRES 2 A 423 LYS LYS ASN THR LEU MET ASP THR SER GLY TYR ASN ALA SEQRES 3 A 423 GLU VAL ARG VAL GLU GLY ASN VAL GLN LEU ASN PRO ILE SEQRES 4 A 423 PHE PRO PHE ASP PHE LYS LEU GLY SER SER GLY ASP ASP SEQRES 5 A 423 ARG GLY LYS VAL ILE VAL THR GLN ASN GLU ASN ILE VAL SEQRES 6 A 423 TYR ASN ALA MET TYR GLU SER PHE SER ILE SER PHE TRP SEQRES 7 A 423 ILE ARG ILE ASN LYS TRP VAL SER ASN LEU PRO GLY TYR SEQRES 8 A 423 THR ILE ILE ASP SER VAL LYS ASN ASN SER GLY TRP SER SEQRES 9 A 423 ILE GLY ILE ILE SER ASN PHE LEU VAL PHE THR LEU LYS SEQRES 10 A 423 GLN ASN GLU ASN SER GLU GLN ASP ILE ASN PHE SER TYR SEQRES 11 A 423 ASP ILE SER LYS ASN ALA ALA GLY TYR ASN LYS TRP PHE SEQRES 12 A 423 PHE VAL THR ILE THR THR ASN MET MET GLY ASN MET MET SEQRES 13 A 423 ILE TYR ILE ASN GLY LYS LEU ILE ASP THR ILE LYS VAL SEQRES 14 A 423 LYS GLU LEU THR GLY ILE ASN PHE SER LYS THR ILE THR SEQRES 15 A 423 PHE GLN MET ASN LYS ILE PRO ASN THR GLY LEU ILE THR SEQRES 16 A 423 SER ASP SER ASP ASN ILE ASN MET TRP ILE ARG ASP PHE SEQRES 17 A 423 TYR ILE PHE ALA LYS GLU LEU ASP ASP LYS ASP ILE ASN SEQRES 18 A 423 ILE LEU PHE ASN SER LEU GLN TYR THR ASN VAL VAL LYS SEQRES 19 A 423 ASP TYR TRP GLY ASN ASP LEU ARG TYR ASP LYS GLU TYR SEQRES 20 A 423 TYR MET ILE ASN VAL ASN TYR MET ASN ARG TYR MET SER SEQRES 21 A 423 LYS LYS GLY ASN GLY ILE VAL PHE ASN THR ARG LYS ASN SEQRES 22 A 423 ASN ASN ASP PHE ASN GLU GLY TYR LYS ILE ILE ILE LYS SEQRES 23 A 423 ARG ILE ARG GLY ASN THR ASN ASP THR ARG VAL ARG GLY SEQRES 24 A 423 GLU ASN VAL LEU TYR PHE ASN THR THR ILE ASP ASN LYS SEQRES 25 A 423 GLN TYR SER LEU GLY MET TYR LYS PRO SER ARG ASN LEU SEQRES 26 A 423 GLY THR ASP LEU VAL PRO LEU GLY ALA LEU ASP GLN PRO SEQRES 27 A 423 MET ASP GLU ILE ARG LYS TYR GLY SER PHE ILE ILE GLN SEQRES 28 A 423 PRO CYS ASN THR PHE ASP TYR TYR ALA SER GLN LEU PHE SEQRES 29 A 423 LEU SER SER ASN ALA THR THR ASN ARG LEU GLY ILE LEU SEQRES 30 A 423 SER ILE GLY SER TYR SER PHE ARG LEU GLY GLY ASP TRP SEQRES 31 A 423 TYR ARG HIS GLU TYR LEU ILE PRO VAL ILE LYS ILE GLU SEQRES 32 A 423 HIS TYR ALA SER LEU LEU GLU SER THR SER THR HIS TRP SEQRES 33 A 423 VAL PHE VAL PRO ALA SER GLU SEQRES 1 B 423 ASN SER ILE ASN ASP SER LYS ILE LEU SER LEU GLN ASN SEQRES 2 B 423 LYS LYS ASN THR LEU MET ASP THR SER GLY TYR ASN ALA SEQRES 3 B 423 GLU VAL ARG VAL GLU GLY ASN VAL GLN LEU ASN PRO ILE SEQRES 4 B 423 PHE PRO PHE ASP PHE LYS LEU GLY SER SER GLY ASP ASP SEQRES 5 B 423 ARG GLY LYS VAL ILE VAL THR GLN ASN GLU ASN ILE VAL SEQRES 6 B 423 TYR ASN ALA MET TYR GLU SER PHE SER ILE SER PHE TRP SEQRES 7 B 423 ILE ARG ILE ASN LYS TRP VAL SER ASN LEU PRO GLY TYR SEQRES 8 B 423 THR ILE ILE ASP SER VAL LYS ASN ASN SER GLY TRP SER SEQRES 9 B 423 ILE GLY ILE ILE SER ASN PHE LEU VAL PHE THR LEU LYS SEQRES 10 B 423 GLN ASN GLU ASN SER GLU GLN ASP ILE ASN PHE SER TYR SEQRES 11 B 423 ASP ILE SER LYS ASN ALA ALA GLY TYR ASN LYS TRP PHE SEQRES 12 B 423 PHE VAL THR ILE THR THR ASN MET MET GLY ASN MET MET SEQRES 13 B 423 ILE TYR ILE ASN GLY LYS LEU ILE ASP THR ILE LYS VAL SEQRES 14 B 423 LYS GLU LEU THR GLY ILE ASN PHE SER LYS THR ILE THR SEQRES 15 B 423 PHE GLN MET ASN LYS ILE PRO ASN THR GLY LEU ILE THR SEQRES 16 B 423 SER ASP SER ASP ASN ILE ASN MET TRP ILE ARG ASP PHE SEQRES 17 B 423 TYR ILE PHE ALA LYS GLU LEU ASP ASP LYS ASP ILE ASN SEQRES 18 B 423 ILE LEU PHE ASN SER LEU GLN TYR THR ASN VAL VAL LYS SEQRES 19 B 423 ASP TYR TRP GLY ASN ASP LEU ARG TYR ASP LYS GLU TYR SEQRES 20 B 423 TYR MET ILE ASN VAL ASN TYR MET ASN ARG TYR MET SER SEQRES 21 B 423 LYS LYS GLY ASN GLY ILE VAL PHE ASN THR ARG LYS ASN SEQRES 22 B 423 ASN ASN ASP PHE ASN GLU GLY TYR LYS ILE ILE ILE LYS SEQRES 23 B 423 ARG ILE ARG GLY ASN THR ASN ASP THR ARG VAL ARG GLY SEQRES 24 B 423 GLU ASN VAL LEU TYR PHE ASN THR THR ILE ASP ASN LYS SEQRES 25 B 423 GLN TYR SER LEU GLY MET TYR LYS PRO SER ARG ASN LEU SEQRES 26 B 423 GLY THR ASP LEU VAL PRO LEU GLY ALA LEU ASP GLN PRO SEQRES 27 B 423 MET ASP GLU ILE ARG LYS TYR GLY SER PHE ILE ILE GLN SEQRES 28 B 423 PRO CYS ASN THR PHE ASP TYR TYR ALA SER GLN LEU PHE SEQRES 29 B 423 LEU SER SER ASN ALA THR THR ASN ARG LEU GLY ILE LEU SEQRES 30 B 423 SER ILE GLY SER TYR SER PHE ARG LEU GLY GLY ASP TRP SEQRES 31 B 423 TYR ARG HIS GLU TYR LEU ILE PRO VAL ILE LYS ILE GLU SEQRES 32 B 423 HIS TYR ALA SER LEU LEU GLU SER THR SER THR HIS TRP SEQRES 33 B 423 VAL PHE VAL PRO ALA SER GLU HET SO4 A1301 5 HET SO4 A1302 5 HET SO4 A1303 5 HET GOL A1304 6 HET GOL B1401 6 HET GOL B1402 6 HET SIA B1403 21 HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETNAM SIA N-ACETYL-ALPHA-NEURAMINIC ACID HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN SIA N-ACETYLNEURAMINIC ACID; SIALIC ACID; ALPHA-SIALIC HETSYN 2 SIA ACID; O-SIALIC ACID FORMUL 3 SO4 3(O4 S 2-) FORMUL 6 GOL 3(C3 H8 O3) FORMUL 9 SIA C11 H19 N O9 FORMUL 10 HOH *190(H2 O) HELIX 1 1 ILE A 864 ASP A 866 5 3 HELIX 2 2 ILE A 925 TYR A 931 5 7 HELIX 3 3 ASP A 992 ASN A 996 5 5 HELIX 4 4 ASP A 1077 LEU A 1088 1 12 HELIX 5 5 ASN A 1114 MET A 1116 5 3 HELIX 6 6 PRO A 1199 GLY A 1207 1 9 HELIX 7 7 SER A 1272 THR A 1275 5 4 HELIX 8 8 ILE B 864 ASP B 866 5 3 HELIX 9 9 ASN B 924 TYR B 931 5 8 HELIX 10 10 ASP B 1077 LEU B 1088 1 12 HELIX 11 11 ASN B 1114 MET B 1116 5 3 HELIX 12 12 PRO B 1199 GLY B 1207 1 9 HELIX 13 13 SER B 1272 THR B 1275 5 4 SHEET 1 A 5 THR A 878 ASP A 881 0 SHEET 2 A 5 LYS A 868 LYS A 875 -1 N GLN A 873 O MET A 880 SHEET 3 A 5 ASN A1063 PHE A1072 -1 O PHE A1069 N LEU A 872 SHEET 4 A 5 PHE A 905 GLY A 908 -1 N LEU A 907 O MET A1064 SHEET 5 A 5 GLN A 896 LEU A 897 -1 N GLN A 896 O LYS A 906 SHEET 1 B 7 THR A 878 ASP A 881 0 SHEET 2 B 7 LYS A 868 LYS A 875 -1 N GLN A 873 O MET A 880 SHEET 3 B 7 ASN A1063 PHE A1072 -1 O PHE A1069 N LEU A 872 SHEET 4 B 7 SER A 933 ASN A 943 -1 N SER A 937 O TYR A1070 SHEET 5 B 7 PHE A1004 ASN A1011 -1 O THR A1010 N PHE A 934 SHEET 6 B 7 ASN A1015 ILE A1020 -1 O TYR A1019 N THR A1007 SHEET 7 B 7 LYS A1023 LYS A1029 -1 O ILE A1028 N MET A1016 SHEET 1 C 7 GLU A 888 GLU A 892 0 SHEET 2 C 7 LYS A 916 THR A 920 -1 O THR A 920 N GLU A 888 SHEET 3 C 7 THR A1041 LYS A1048 -1 O ILE A1042 N VAL A 919 SHEET 4 C 7 TYR A 952 VAL A 958 -1 N ILE A 954 O GLN A1045 SHEET 5 C 7 GLY A 963 ILE A 968 -1 O ILE A 966 N ILE A 954 SHEET 6 C 7 PHE A 972 LYS A 978 -1 O THR A 976 N SER A 965 SHEET 7 C 7 GLU A 984 SER A 990 -1 O GLN A 985 N LEU A 977 SHEET 1 D13 VAL A1163 THR A1169 0 SHEET 2 D13 GLN A1174 MET A1179 -1 O TYR A1175 N THR A1168 SHEET 3 D13 LEU A1190 LEU A1196 -1 O GLY A1194 N GLY A1178 SHEET 4 D13 HIS A1254 ILE A1263 -1 O PRO A1259 N LEU A1193 SHEET 5 D13 ARG A1234 PHE A1245 -1 N GLY A1241 O ILE A1258 SHEET 6 D13 TYR A1220 SER A1227 -1 N LEU A1226 O LEU A1235 SHEET 7 D13 VAL A1163 THR A1169 0 SHEET 8 D13 ILE A1144 ARG A1150 -1 N ILE A1145 O ASN A1167 SHEET 9 D13 GLU A1107 ASN A1112 -1 N TYR A1108 O ILE A1144 SHEET 10 D13 TRP A1277 PRO A1281 -1 O VAL A1278 N ILE A1111 SHEET 11 D13 TYR A1220 SER A1227 -1 N SER A1222 O TRP A1277 SHEET 12 D13 PHE A1209 ASN A1215 -1 N ILE A1210 O PHE A1225 SHEET 13 D13 TYR A1220 SER A1227 -1 O PHE A1225 N ILE A1210 SHEET 1 E 2 ARG A1118 LYS A1123 0 SHEET 2 E 2 GLY A1126 THR A1131 -1 O ASN A1130 N TYR A1119 SHEET 1 F 5 LEU B 879 ASP B 881 0 SHEET 2 F 5 LYS B 868 ASN B 874 -1 N GLN B 873 O MET B 880 SHEET 3 F 5 ASN B1063 PHE B1072 -1 O ILE B1071 N ILE B 869 SHEET 4 F 5 PHE B 905 GLY B 908 -1 N LEU B 907 O MET B1064 SHEET 5 F 5 GLN B 896 LEU B 897 -1 N GLN B 896 O LYS B 906 SHEET 1 G 7 LEU B 879 ASP B 881 0 SHEET 2 G 7 LYS B 868 ASN B 874 -1 N GLN B 873 O MET B 880 SHEET 3 G 7 ASN B1063 PHE B1072 -1 O ILE B1071 N ILE B 869 SHEET 4 G 7 SER B 933 ASN B 943 -1 N SER B 937 O TYR B1070 SHEET 5 G 7 PHE B1004 ASN B1011 -1 O THR B1010 N PHE B 934 SHEET 6 G 7 ASN B1015 ILE B1020 -1 O TYR B1019 N THR B1007 SHEET 7 G 7 LYS B1023 LYS B1029 -1 O LYS B1023 N ILE B1020 SHEET 1 H 7 GLU B 888 GLU B 892 0 SHEET 2 H 7 LYS B 916 THR B 920 -1 O ILE B 918 N ARG B 890 SHEET 3 H 7 THR B1041 LYS B1048 -1 O ILE B1042 N VAL B 919 SHEET 4 H 7 TYR B 952 VAL B 958 -1 N ASP B 956 O THR B1043 SHEET 5 H 7 GLY B 963 ILE B 969 -1 O ILE B 968 N TYR B 952 SHEET 6 H 7 PHE B 972 LYS B 978 -1 O THR B 976 N SER B 965 SHEET 7 H 7 GLN B 985 SER B 990 -1 O PHE B 989 N LEU B 973 SHEET 1 I13 VAL B1163 THR B1169 0 SHEET 2 I13 GLN B1174 MET B1179 -1 O TYR B1175 N THR B1168 SHEET 3 I13 LEU B1190 LEU B1196 -1 O GLY B1194 N GLY B1178 SHEET 4 I13 HIS B1254 ILE B1263 -1 O ILE B1261 N VAL B1191 SHEET 5 I13 ARG B1234 PHE B1245 -1 N GLY B1241 O ILE B1258 SHEET 6 I13 TYR B1220 SER B1227 -1 N LEU B1224 O LEU B1238 SHEET 7 I13 VAL B1163 THR B1169 0 SHEET 8 I13 ILE B1144 ARG B1150 -1 N LYS B1147 O TYR B1165 SHEET 9 I13 GLU B1107 ASN B1112 -1 N TYR B1108 O ILE B1144 SHEET 10 I13 TRP B1277 PRO B1281 -1 O VAL B1278 N ILE B1111 SHEET 11 I13 TYR B1220 SER B1227 -1 N SER B1222 O TRP B1277 SHEET 12 I13 PHE B1209 ASN B1215 -1 N GLN B1212 O GLN B1223 SHEET 13 I13 TYR B1220 SER B1227 -1 O GLN B1223 N GLN B1212 SHEET 1 J 2 ARG B1118 LYS B1123 0 SHEET 2 J 2 GLY B1126 THR B1131 -1 O ASN B1130 N TYR B1119 CISPEP 1 PHE A 901 PRO A 902 0 0.70 CISPEP 2 PHE B 901 PRO B 902 0 0.00 CRYST1 82.603 154.630 181.029 90.00 90.00 90.00 I 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012106 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006467 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005524 0.00000